BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CARS, P49589, 833, ENSG00000110619 AND Prognosis
30 results:

  • 1. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
    Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
    J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting prognosis.
    Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
    Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Marital Status as an Independent Prognostic Factor in Patients with Glioblastoma: A Population-Based Study.
    Hu S; Sun C; Chen M; Zhou J
    World Neurosurg; 2024 Feb; 182():e559-e569. PubMed ID: 38061540
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma.
    Teppert K; Winter N; Herbel V; Brandes C; Lennartz S; Engert F; Kaiser A; Schaser T; Lock D
    Front Immunol; 2023; 14():1178060. PubMed ID: 37901209
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas.
    Wang H; Zeng L; Wu H; Tian J; Xie H; Zhang L; Ran Q; Zhong P; Chen L; Yi L; Wang S
    Eur Radiol; 2024 Mar; 34(3):1982-1993. PubMed ID: 37658897
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of prognostic factors and establishment of prognostic model for primary mediastinal germ cell tumors: a case controlled study.
    Leng C; Cui Y; Mai Z; Chen R; Yuan J; Wang K; Wen J; Fu J; Liu Q
    Int J Surg; 2023 Sep; 109(9):2574-2584. PubMed ID: 37222675
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients.
    Ferrer VP
    Cancer Genet; 2023 Jan; 270-271():22-30. PubMed ID: 36436416
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [The influence of lung metastasis on prognosis of previously untreated gestational trophoblastic neoplasia patients].
    Lin JJ; Jiang F; Xiang Y; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
    Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1139-1145. PubMed ID: 36319461
    [No Abstract]    [Full Text] [Related]  

  • 9. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
    Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
    Front Immunol; 2022; 13():867154. PubMed ID: 35603195
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chimeric Antigen Receptor (CAR) T cell Therapy for Glioblastoma.
    Verma A; Rafiq S
    Cancer Treat Res; 2022; 183():161-184. PubMed ID: 35551659
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A model for predicting the overall survival of gastroenteropancreatic neuroendocrine neoplasms after surgery.
    Feng LH; Su T; Lu Y; Ren S; Huang L; Qin X; Liao T
    Scand J Gastroenterol; 2022 May; 57(5):581-588. PubMed ID: 35001789
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging for distinguishing pseudoprogression from glioma recurrence: a meta-analysis.
    Qiu J; Tao ZC; Deng KX; Wang P; Chen CY; Xiao F; Luo Y; Yuan SY; Chen H; Huang H
    Chin Med J (Engl); 2021 Oct; 134(21):2535-2543. PubMed ID: 34748524
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Intraoperative radiotherapy for glioblastoma: A systematic review of techniques and outcomes.
    Ylanan AMD; Pascual JSG; Cruz-Lim EMD; Ignacio KHD; Cañal JPA; Khu KJO
    J Clin Neurosci; 2021 Nov; 93():36-41. PubMed ID: 34656258
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CXCR6 is required for antitumor efficacy of intratumoral CD8
    Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chimeric Antigen Receptor T cells for Glioblastoma: Current Concepts, Challenges, and Future Perspectives.
    Karschnia P; Teske N; Thon N; Subklewe M; Tonn JC; Dietrich J; von Baumgarten L
    Neurology; 2021 Aug; 97(5):218-230. PubMed ID: 33986138
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
    Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
    Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis.
    Zhang Y; Chen J; Xue Q; Wang J; Zhao L; Han K; Zhang D; Hou L
    Biomed Res Int; 2019; 2019():4015969. PubMed ID: 31032345
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
    Norden AD; Korytowsky B; You M; Kim Le T; Dastani H; Bobiak S; Singh P
    J Manag Care Spec Pharm; 2019 Apr; 25(4):428-436. PubMed ID: 30917077
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
    Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
    J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.